Berti, A., Bortolotti, R., Dipasquale, M., Kinspergher, S., Prokop, L., Grandi, G., . . . Veccia, A. (2021). Meta-analysis of immune-related adverse events in phase 3 clinical trials assessing immune checkpoint inhibitors for lung cancer. Critical reviews in oncology/hematology, 162, 103351. https://doi.org/10.1016/j.critrevonc.2021.103351
Citace podle Chicago (17th ed.)Berti, Alvise, et al. "Meta-analysis of Immune-related Adverse Events in Phase 3 Clinical Trials Assessing Immune Checkpoint Inhibitors for Lung Cancer." Critical Reviews in Oncology/hematology 162 (2021): 103351. https://doi.org/10.1016/j.critrevonc.2021.103351.
Citace podle MLA (9th ed.)Berti, Alvise, et al. "Meta-analysis of Immune-related Adverse Events in Phase 3 Clinical Trials Assessing Immune Checkpoint Inhibitors for Lung Cancer." Critical Reviews in Oncology/hematology, vol. 162, 2021, p. 103351, https://doi.org/10.1016/j.critrevonc.2021.103351.